WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008095823) 5 -AMIDO- (IH- INDOL- 2 -YL) PIPERAZIN-1-YL-METHANONE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/095823    International Application No.:    PCT/EP2008/051002
Publication Date: 14.08.2008 International Filing Date: 29.01.2008
IPC:
C07D 209/42 (2006.01), C07D 401/04 (2006.01), C07D 403/06 (2006.01), A61K 31/404 (2006.01), A61P 3/04 (2006.01), A61P 3/10 (2006.01)
Applicants: F. HOFFMANN-LA ROCHE AG [CH/CH]; Grenzacherstrasse 124, CH-4070 Basel (CH) (For All Designated States Except US).
NETTEKOVEN, Matthias [DE/DE]; (DE) (For US Only).
PLANCHER, Jean-Marc [FR/FR]; (FR) (For US Only).
RICHTER, Hans [DE/DE]; (DE) (For US Only).
ROCHE, Olivier [FR/FR]; (FR) (For US Only).
TAYLOR, Sven [FR/FR]; (FR) (For US Only)
Inventors: NETTEKOVEN, Matthias; (DE).
PLANCHER, Jean-Marc; (FR).
RICHTER, Hans; (DE).
ROCHE, Olivier; (FR).
TAYLOR, Sven; (FR)
Agent: KLOSTERMEYER, Doerte; Grenzacherstrasse 124, CH-4070 Basel (CH)
Priority Data:
07101883.2 07.02.2007 EP
Title (EN) 5 -AMIDO- (IH- INDOL- 2 -YL) PIPERAZIN-1-YL-METHANONE DERIVATIVES AS HISTAMINE H3 RECEPTOR LIGANDS
(FR) DÉRIVÉS DE 5-AMIDO-(1H-INDOL-2-YL)-PIPÉRAZINE-1-YL-MÉTHANONE UTILISÉS COMME LIGANDS DU RÉCEPTEUR H3 DE L'HISTAMINE
Abstract: front page image
(EN)The present invention relates to compounds of formula (I): wherein A, G and R1 to R3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
(FR)La présente invention porte sur des composés de formule (I) : dans laquelle A, G et R1 à R3 sont tels que définis dans la description et les revendications, ainsi que sur des sels pharmaceutiquement acceptables de ceux-ci. Les composés sont utiles pour le traitement et/ou la prévention de maladies associées à la modulation des récepteurs H3.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)